Dual checkpoint blockade of CD47 and PD-L1 using an affinity-tuned bispecific antibody maximizes antitumor immunity
===================================================================================================================

* Shih-Hsun Chen
* Pawel K Dominik
* Jessica Stanfield
* Sheng Ding
* Wenjing Yang
* Nadia Kurd
* Ryan Llewellyn
* Jonathan Heyen
* Carole Wang
* Zea Melton
* Thomas Van Blarcom
* Kevin C Lindquist
* Javier Chaparro-Riggers
* Shahram Salek-Ardakani